Shares of Tenet Healthcare Corporation (NYSE:THC) have been given a consensus recommendation of “Hold” by the nineteen brokerages that are currently covering the company, Marketbeat reports. Three investment analysts have rated the stock with a sell rating, nine have issued a hold rating, six have assigned a buy rating and one has issued a strong buy rating on the company. The average 1-year target price among analysts that have issued a report on the stock in the last year is $21.43.

A number of research firms have recently commented on THC. Wells Fargo & Company upgraded shares of Tenet Healthcare Corporation from a “market perform” rating to an “outperform” rating and set a $22.00 price target for the company in a research report on Tuesday, June 6th. Zacks Investment Research raised shares of Tenet Healthcare Corporation from a “hold” rating to a “strong-buy” rating and set a $21.00 price target for the company in a research note on Monday, July 10th. Citigroup Inc. reissued a “neutral” rating and issued a $16.00 price target (down from $20.00) on shares of Tenet Healthcare Corporation in a research note on Thursday, August 10th. Leerink Swann raised shares of Tenet Healthcare Corporation from a “market perform” rating to an “outperform” rating and set a $27.00 price target for the company in a research note on Tuesday, June 6th. Finally, Morgan Stanley began coverage on shares of Tenet Healthcare Corporation in a research note on Tuesday, June 6th. They issued an “equal weight” rating and a $19.00 price target for the company.

Shares of Tenet Healthcare Corporation (NYSE:THC) traded down 3.03% during mid-day trading on Tuesday, hitting $16.95. The company’s stock had a trading volume of 519,109 shares. The company has a 50-day moving average of $17.03 and a 200 day moving average of $17.80. The company’s market cap is $1.71 billion. Tenet Healthcare Corporation has a 1-year low of $12.54 and a 1-year high of $24.86.

Tenet Healthcare Corporation (NYSE:THC) last released its quarterly earnings results on Monday, August 7th. The company reported ($0.17) EPS for the quarter, meeting analysts’ consensus estimates of ($0.17). The firm had revenue of $14.80 billion during the quarter, compared to analyst estimates of $4.90 billion. Tenet Healthcare Corporation had a negative net margin of 0.97% and a negative return on equity of 2.00%. The business’s revenue for the quarter was up 204.1% on a year-over-year basis. During the same period in the previous year, the business earned $0.38 EPS. On average, analysts expect that Tenet Healthcare Corporation will post $0.83 EPS for the current year.

Large investors have recently bought and sold shares of the stock. UBS Asset Management Americas Inc. boosted its stake in Tenet Healthcare Corporation by 634.6% in the first quarter. UBS Asset Management Americas Inc. now owns 816,416 shares of the company’s stock worth $14,459,000 after buying an additional 705,276 shares during the last quarter. Comerica Bank boosted its stake in Tenet Healthcare Corporation by 5.0% in the first quarter. Comerica Bank now owns 61,863 shares of the company’s stock worth $957,000 after buying an additional 2,963 shares during the last quarter. BNP Paribas Arbitrage SA boosted its stake in Tenet Healthcare Corporation by 65.0% in the first quarter. BNP Paribas Arbitrage SA now owns 49,539 shares of the company’s stock worth $877,000 after buying an additional 19,508 shares during the last quarter. Bank of New York Mellon Corp boosted its stake in Tenet Healthcare Corporation by 3.5% in the first quarter. Bank of New York Mellon Corp now owns 1,041,675 shares of the company’s stock worth $18,449,000 after buying an additional 34,995 shares during the last quarter. Finally, First Trust Advisors LP boosted its stake in Tenet Healthcare Corporation by 583.0% in the first quarter. First Trust Advisors LP now owns 180,398 shares of the company’s stock worth $3,195,000 after buying an additional 153,984 shares during the last quarter.

COPYRIGHT VIOLATION WARNING: This piece of content was originally posted by Watch List News and is the property of of Watch List News. If you are viewing this piece of content on another website, it was stolen and republished in violation of international copyright and trademark laws. The correct version of this piece of content can be read at https://www.watchlistnews.com/tenet-healthcare-corporation-thc-receives-consensus-recommendation-of-hold-from-brokerages/1529659.html.

Tenet Healthcare Corporation Company Profile

Tenet Healthcare Corporation (Tenet) is a healthcare services company. The Company operates regionally focused, integrated healthcare delivery networks in large urban and suburban markets in the United States. The Company’s segments include Hospital Operations and Other, Ambulatory Care and Conifer. As of December 31, 2016, its subsidiaries operated 79 hospitals, including three academic medical centers, two children’s hospitals, two specialty hospitals and one critical access hospital.

Analyst Recommendations for Tenet Healthcare Corporation (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.